Nureca promoter Aryan Goyal resigns as CEO, transfers shares

Nureca Limited disclosed a Family Settlement Agreement (FSA) dated June 17, 2026, executed among promoter group members, which will result in the transfer of shares and a change in the company's top management. The agreement involves Mr. Saurabh Goyal and Ms. Smita Goyal on one side, and Mr. Aryan Goyal and Ms. Payal Goyal on the other. The company stated it is not a party to the agreement and has not independently verified its contents, making the disclosure based on information provided by the promoters for compliance with Regulation 30A of the LODR Regulations.

Under the terms of the FSA, Mr. Aryan Goyal and his wife, Ms. Payal Goyal, will transfer all their shares in the company to Mr. Saurabh Goyal. Additionally, Mr. Aryan Goyal will step down from his position as CEO and resign as a director of the company. The agreement aims to facilitate family settlement, succession planning, and the realignment of ownership interests and management responsibilities.

The share transfer will significantly alter the shareholding pattern within the promoter group. Mr. Saurabh Goyal, currently the Chairman & Managing Director and sole promoter, will see his individual voting rights increase substantially. The transaction is exempt from open offer obligations under Regulation 10(1)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as it involves an inter-se transfer among promoter group members.

The following table details the changes in shareholding pre- and post-transfer:

Name	Category	Pre-Transfer Shares	Pre-Transfer Voting Rights (%)	Post-Transfer Shares	Post-Transfer Voting Rights (%)	Difference (%)
SAURABH GOYAL	Promoter	32,78,056	34.35	64,97,169	68.09	33.74
SMITA GOYAL	Promoter Group	7	0.00	7	0.00	-
PAYAL GOYAL	Promoter Group	20,59,928	21.59	0	-	-21.59
ARYAN GOYAL	Promoter Group	11,59,185	12.15	0	-	-12.15
PUBLIC	Public	30,44,744	31.91	30,44,744	31.91	-
Grand Total		95,41,920	100.00	95,41,920	100.00	-

Mr. Saurabh Goyal currently exercises control over the company's affairs. While the transfer does not result in the acquisition of fresh control, it strengthens his existing position by increasing his individual voting rights beyond 50%. The company confirmed that the FSA does not impose any obligation, liability, or restriction upon Nureca Limited. Any consequential changes in shareholding, promoter classification, or governance rights will be disclosed separately as they occur.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.65%	+2.80%	-13.69%	-15.91%	-12.90%	-84.68%

Nureca Limited announced that its connected health platform, Dr Trust 360, has surpassed 2.4 million registered users. The company also launched Dr Trust Intelligence, an AI-powered analytics suite within the app designed to interpret body-composition data and provide personalized health guidance. This development aims to enhance user understanding of health trends through India-based data infrastructure.

The Dr Trust Intelligence suite analyzes readings from compatible 4-electrode and 8-electrode smart body-composition scales. It offers plain-language interpretation of metrics such as body fat, muscle mass, and visceral fat. The system features automatic detection of meaningful changes and longer-term trends based on user history, along with AI-based diet guidance and actionable recommendations.

Key Capabilities

The new analytics suite focuses on converting raw measurements into actionable insights. Key features include:

Personalized health analysis to track progress rather than isolated readings.
Clear reports designed to support informed conversations with healthcare professionals.
Automatic trend detection based on individual user history.
AI-guided diet plans aligned with specific health goals.

Saurabh Goyal, Chairman and Managing Director of nureca , stated that the milestone reflects the trust Indian families place in the Dr Trust ecosystem. He emphasized that the combination of intelligent analytics with India-based data infrastructure makes connected preventive healthcare more useful and secure.

Device and Data Infrastructure

Dr Trust's 8-electrode smart scales measure through both hands and feet, offering a detailed view of body composition. Company validation testing indicates up to 98% DEXA-level accuracy for selected metrics, including body fat, muscle mass, and visceral fat. The Dr Trust 360 app integrates compatible devices such as smart body-composition scales, blood pressure monitors, and smart kitchen scales into a single ecosystem.

To ensure data security and compliance, user health data is encrypted and stored on servers located in India. This approach keeps sensitive health records within Indian jurisdiction and aligns with applicable data-protection requirements. Dr Trust Intelligence is available as a premium subscription on Android and iOS platforms.